Format

Send to

Choose Destination
J Hepatol. 2016 Dec;65(6):1268-1269. doi: 10.1016/j.jhep.2016.07.032. Epub 2016 Jul 29.

A strong message is needed to address the issue of HCC recurrence after DAA therapy.

Author information

1
Hepatology, Department of Clinical Research, University of Bern, Bern, Switzerland; University Clinic for Visceral Surgery and Medicine, Inselspital Bern, Bern, Switzerland. Electronic address: philippe.kolly@insel.ch.
2
Hepatology, Department of Clinical Research, University of Bern, Bern, Switzerland; University Clinic for Visceral Surgery and Medicine, Inselspital Bern, Bern, Switzerland.
PMID:
27480589
DOI:
10.1016/j.jhep.2016.07.032
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center